Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial
Ann Surg Oncol
.
2026 Aug;33(8):6927-6929.
doi: 10.1245/s10434-026-19938-x.
Epub 2026 Jun 4.
Authors
Edmund K Bartlett
1
,
Christopher A Barker
2
Affiliations
1
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bartlete@mskcc.org.
2
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
42240785
DOI:
10.1245/s10434-026-19938-x
No abstract available
Publication types
Editorial